Your browser is no longer supported. Please, upgrade your browser.
Settings
BIOC Biocept, Inc. daily Stock Chart
BIOC [NASD]
Biocept, Inc.
Index- P/E- EPS (ttm)-1.26 Insider Own1.00% Shs Outstand30.24M Perf Week-2.46%
Market Cap35.99M Forward P/E- EPS next Y-0.66 Insider Trans0.00% Shs Float27.15M Perf Month-7.03%
Income-19.10M PEG- EPS next Q-0.20 Inst Own17.30% Short Float9.92% Perf Quarter-17.93%
Sales5.30M P/S6.79 EPS this Y37.50% Inst Trans151.09% Short Ratio9.48 Perf Half Y-28.74%
Book/sh0.50 P/B2.38 EPS next Y- ROA-209.70% Target Price- Perf Year32.16%
Cash/sh0.46 P/C2.57 EPS next 5Y10.00% ROE- 52W Range0.74 - 3.39 Perf YTD53.55%
Dividend- P/FCF- EPS past 5Y35.10% ROI- 52W High-64.90% Beta3.04
Dividend %- Quick Ratio2.80 Sales past 5Y398.00% Gross Margin-56.10% 52W Low60.79% ATR0.07
Employees42 Current Ratio2.90 Sales Q/Q750.00% Oper. Margin- RSI (14)42.17 Volatility5.20% 5.63%
OptionableYes Debt/Eq0.12 EPS Q/Q71.50% Profit Margin- Rel Volume1.17 Prev Close1.23
ShortableYes LT Debt/Eq0.08 EarningsNov 09 AMC Payout- Avg Volume283.92K Price1.19
Recom- SMA20-3.85% SMA50-5.40% SMA200-24.06% Volume329,303 Change-3.25%
Jun-02-17Initiated Chardan Capital Markets Buy $2.50
Jun-06-16Initiated ROTH Capital Buy $1.20
Aug-19-15Initiated H.C. Wainwright Buy $4
Jun-03-14Initiated Aegis Capital Buy $16
Oct-11-17 08:05AM  Renowned Lung Cancer Expert Fred R. Hirsch, M.D., Ph.D. Joins Biocept's Clinical Advisory Board PR Newswire
Oct-10-17 11:03AM  ETFs with exposure to Biocept, Inc. : October 10, 2017 Capital Cube
Oct-04-17 06:46PM  What You Must Know About Biocept Incs (BIOC) Risks Simply Wall St.
09:20AM  Biocept, Inc. :BIOC-US: Earnings Analysis: Q2, 2017 By the Numbers : October 4, 2017 Capital Cube
Oct-03-17 08:05AM  Biocept and Miraca Life Sciences Enter Into Marketing Agreement to Expand Target Selector Testing in the United States PR Newswire
Sep-19-17 09:35AM  5 Medtech Stocks to Steer Clear of Amid Political Chaos Zacks
Sep-05-17 08:05AM  Biocept Launches Liquid Biopsy Test for NRAS Mutations PR Newswire
Aug-28-17 08:05AM  Biocept to Present at the 6th Annual Gateway Conference on September 6, 2017 in San Francisco PR Newswire
Aug-17-17 08:05AM  Biocept and UT Southwestern Medical Center Announce Clinical Study to Profile and Monitor Non-Small Cell Lung Cancer Patients with ALK Rearrangements PR Newswire
Aug-14-17 08:05AM  Biocept Enters Into Exclusive Distribution Agreement with Global Laboratory Product Supplier VWR PR Newswire
Aug-10-17 04:05PM  Biocept Reports Second Quarter 2017 Financial Results PR Newswire
12:30PM  Investor Network: Biocept, Inc. to Host Earnings Call ACCESSWIRE
08:05AM  Biocept Announces Private Placement of $2.2 Million of Common Stock with Ally Bridge LB Healthcare Master Fund PR Newswire
Aug-07-17 08:05AM  Biocept Executes Preferred Provider Agreement with Scripps Health Plan Expanding Patient Coverage for its Liquid Biopsy Platform PR Newswire +7.69%
Aug-03-17 07:47PM  ETFs with exposure to Biocept, Inc. : August 3, 2017 Capital Cube
08:05AM  Biocept to Release Second Quarter 2017 Financial Results and Host Investor Conference Call on August 10, 2017 PR Newswire
Jul-26-17 08:10AM  Global stocks rise on corporate earnings, ahead of Fed Associated Press
07:58AM  Drugmaker GSK reviewing its R&D programs under new CEO Associated Press
Jul-17-17 07:40AM  Featured Company News - Biocept Commercially Launches Progesterone Receptor Liquid Biopsy Test Accesswire
Jul-14-17 08:05AM  Biocept Expands Commercial Offering of Clinically Actionable Biomarker Assays with Launch of Liquid Biopsy Test for Progesterone Receptor Detection PR Newswire
Jul-12-17 06:21PM  Novel leukemia treatment could be 1st US gene therapy Associated Press
02:15PM  ETFs with exposure to Biocept, Inc. : July 12, 2017 Capital Cube
Jun-28-17 02:35PM  ETFs with exposure to Biocept, Inc. : June 28, 2017 Capital Cube
Jun-26-17 08:05AM  Biocept Added to the Russell Microcap Index PR Newswire
Jun-21-17 08:05AM  Biocept and MediNcrease Health Plans Announce Provider Agreement Expanding Access to Liquid Biopsy Testing PR Newswire +7.69%
Jun-16-17 03:27PM  ETFs with exposure to Biocept, Inc. : June 16, 2017 Capital Cube -5.34%
Jun-05-17 02:03PM  ETFs with exposure to Biocept, Inc. : June 5, 2017 Capital Cube
Jun-02-17 10:16AM  Biocept, Inc. :BIOC-US: Earnings Analysis: Q1, 2017 By the Numbers : June 2, 2017 Capital Cube
May-23-17 08:00AM  Today's Research Reports on Stocks to Watch: Radius Health and Biocept Inc. Accesswire
May-22-17 08:05AM  Biocept Awarded U.S. Patent with Broad Claims for Antibody Capture of Targets of Interest on Any Solid Surface Including CTCs and Other Materials Shed by Solid Tumors into Blood PR Newswire +6.29%
May-18-17 10:33AM  Vaccine may cut HPV infections, an oral cancer risk, in men Associated Press
08:05AM  Biocept's Target Selector Platform Featured in Three Clinical Abstracts at the 2017 American Society of Clinical Oncology Annual Meeting Where Company Plans to Launch New Marketing Campaign PR Newswire
May-15-17 08:00AM  Today's Research Reports on Stocks to Watch: Biocept and Hornbeck Offshore Services Accesswire
May-12-17 03:43PM  ETFs with exposure to Biocept, Inc. : May 12, 2017 Capital Cube -13.66%
May-11-17 04:05PM  Biocept Reports First Quarter 2017 Financial Results PR Newswire
03:30PM  Investor Network: Biocept, Inc. to Host Earnings Call Accesswire
May-10-17 08:05AM  The Addario Lung Cancer Medical Institute and Biocept Announce Collaboration and Initiation of Landmark ALCMI-009 Liquid Biopsy Clinical Trial in Lung Cancer PR Newswire
May-03-17 08:05AM  Biocept to Release First Quarter 2017 Financial Results and Host Investor Conference Call on May 11, 2017 PR Newswire
May-01-17 03:41PM  ETFs with exposure to Biocept, Inc. : May 1, 2017 Capital Cube
Apr-26-17 08:31AM  GSK warns of impact from generic drugs after solid Q1 Associated Press
Apr-21-17 12:00AM  $3M award in suit against drug company over man's suicide Associated Press
Apr-20-17 02:13PM  ETFs with exposure to Biocept, Inc. : April 20, 2017 Capital Cube
Apr-18-17 08:05AM  Biocept Awarded Additional Patent in Japan Expanding Intellectual Property Estate to 19 Issued Patents Protecting Its Target Selector Liquid Biopsy Platform PR Newswire
Apr-05-17 04:24PM  ETFs with exposure to Biocept, Inc. : April 5, 2017 Capital Cube
04:07AM  FDA pick faces questioning on ties to industry he'd regulate Associated Press
04:07AM  FDA pick faces questioning on ties to industry he'd regulate
Apr-03-17 08:05AM  Biocept Announces Collaboration with the OHSU Knight Cancer Institute to Increase Clinical Adoption of Liquid Biopsy Testing and to Co-Develop Additional Assay Platform Capabilities PR Newswire
Mar-31-17 01:04PM  BIOCEPT INC Financials
01:03PM  Biocept to Present at The MicroCap Conference on April 4th in New York City PR Newswire
Mar-30-17 04:11PM  BIOCEPT INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, O
09:06AM  Biocept, Inc. :BIOC-US: Earnings Analysis: Q4, 2016 By the Numbers : March 30, 2017 Capital Cube
Mar-28-17 09:10AM  Biocept Announces Pricing of $9.3 Million Financing PR Newswire
06:35AM  BIOCEPT INC Files SEC form 10-K, Annual Report
Mar-23-17 04:12PM  BIOCEPT INC Files SEC form 8-K, Shareholder Director Nominations
09:30AM  Biocept and OvaScience Post Gains Amid Investor Speculation Accesswire
Mar-20-17 08:05AM  Biocept Announces Revised Presentation Time at the 27th Annual Oppenheimer Healthcare Conference PR Newswire
Mar-15-17 08:05AM  Biocept to Present at the 27th Annual Oppenheimer Healthcare Conference PR Newswire
Mar-14-17 11:38AM  Couple sue pharma giant for work that led to prison in China Associated Press
08:05AM  Biocept and Catalyst Pharmaceuticals Collaborate to Provide Liquid Biopsy Testing for Small Cell Lung Cancer to Patients with Lambert Eaton Myasthenic Syndrome (LEMS) PR Newswire
Mar-11-17 02:55AM  Trump's choice for FDA has ties to Wall Street, drug makers
Mar-10-17 07:21PM  Trump picks former FDA official to head food and drug agency
Mar-08-17 08:05AM  Biocept to Present at the 29th Annual ROTH Conference PR Newswire
Mar-07-17 04:06PM  BIOCEPT INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits -5.04%
04:05PM  Biocept Reports Fourth Quarter and Full Year 2016 Financial Results PR Newswire
07:07AM  Q4 2016 Biocept Inc Earnings Release - After Market Close
Feb-21-17 08:05AM  Biocept to Release 2016 Fourth Quarter and Full Year Financial Results and Host Investor Conference Call on March 7, 2017 PR Newswire
Feb-15-17 08:05AM  Biocept Appoints Michael Terry Senior Vice President Commercial Operations PR Newswire
Feb-09-17 08:12AM  BIOCEPT INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits +29.59%
08:05AM  Biocept's CEO Issues Letter to Stockholders PR Newswire
Feb-08-17 11:57AM  GSK warns profits to be hit by generic drugs competition +7.64%
Feb-06-17 08:05AM  Biocept to Present at the 19th Annual BIO CEO and Investor Conference PR Newswire
Jan-25-17 09:01AM  BIOCEPT INC Files SEC form 8-K, Other Events -5.33%
Jan-19-17 12:26PM  ETFs with exposure to Biocept, Inc. : January 19, 2017 +9.27%
09:05AM  Biocept Awarded Patent in Australia for the Use of Antibodies in Microchannels to Capture Circulating Tumor Cells and Other Rare Cells PR Newswire
Jan-13-17 09:30AM  Latest Reports on Biocept and Apricus Biosciences as President Trump's Comments Put Pressure on Drug Manufacturers Accesswire
Jan-10-17 03:30PM  Tuesdays Top Biopharma Movers +77.45%
09:36AM  Biocept Secures In-Network Provider Agreement with Blue Cross Blue Shield of Texas PR Newswire
Dec-27-16 08:05AM  Columbia University Medical Center Sponsors Clinical Study Using Biocept's Liquid Biopsy Platform to Evaluate Cerebrospinal Fluid of Breast Cancer Patients for Metastatic Biomarkers PR Newswire
Dec-08-16 08:05AM  Clinical Utility of Biocept's Liquid Biopsy Platform Demonstrated in Study Results Presented at the 2016 San Antonio Breast Cancer Symposium PR Newswire
Dec-07-16 09:45AM  Biocept Presents Robust Analytical Validation Study Results for its PD-L1 Liquid Biopsy Test at the 17th IASLC World Conference on Lung Cancer PR Newswire
08:04AM  Teladoc November Visits Set Record: Why is Stock Suffering?
Dec-05-16 11:51AM  ETFs with exposure to Biocept, Inc. : December 5, 2016
Dec-02-16 05:11PM  BIOCEPT INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Trans
Nov-21-16 08:05AM  Biocept to Present at the LD Micro Main Event PR Newswire
Nov-14-16 12:56PM  ETFs with exposure to Biocept, Inc. : November 14, 2016
Nov-10-16 04:09PM  BIOCEPT INC Files SEC form 10-Q, Quarterly Report +6.96%
11:46AM  Biocept, Inc. :BIOC-US: Earnings Analysis: Q3, 2016 By the Numbers : November 10, 2016
Nov-09-16 04:16PM  BIOCEPT INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:05PM  Biocept Reports 2016 Third Quarter Financial Results PR Newswire
07:07AM  Q3 2016 Biocept Inc Earnings Release - After Market Close
Nov-04-16 04:22PM  BIOCEPT INC Files SEC form 8-K, Termination of a Material Definitive Agreement
Oct-31-16 08:05AM  Biocept to Release Third Quarter Financial Results and Host Investor Conference Call on November 9, 2016 PR Newswire -6.02%
Oct-28-16 05:18PM  BIOCEPT INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Trans
Oct-27-16 08:05AM  Biocept Appoints David Moskowitz Vice President, Strategy & Corporate Communications PR Newswire
Oct-26-16 08:03AM  GSK sees earnings rise amid good demand for vaccines +5.20%
Oct-20-16 08:05AM  Study Results Presented at the 2016 ESMO Annual Congress Demonstrate Leading Clinical Performance with Biocept's ctDNA Liquid Biopsy Platform vs. Tissue Biopsy PR Newswire
Oct-19-16 04:25PM  Biocept Announces Closing of $10 Million Public Offering of Common Stock and Warrants PR Newswire
Oct-18-16 09:48AM  ETFs with exposure to Biocept, Inc. : October 18, 2016
Oct-14-16 08:05AM  Biocept Announces Pricing of $10 Million Public Offering of Common Stock and Warrants PR Newswire -21.64%
Oct-05-16 08:05AM  /C O R R E C T I O N -- Biocept, Inc./ PR Newswire +5.19%
Biocept, Inc., an early stage molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. The company's cancer assays provide information to oncologists and other physicians that enable them to select personalized treatment for their patients who have been diagnosed with cancer based on molecular drivers. It offers assays for solid tumor indications, such as breast cancer, non-small cell lung cancer, small cell lung cancer, gastric cancer, colorectal cancer, prostate cancer, and melanoma. The company sells its cancer diagnostic assays directly to oncologists and other physicians at private and group practices, hospitals, and cancer centers in the United States, as well as markets its clinical trial and research services to pharmaceutical and biopharmaceutical companies, and clinical research organizations. Biocept, Inc. was founded in 1997 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Neff Edward A.DirectorOct 19Buy1.10227,272249,999289,735Oct 21 05:06 PM
HALE DAVID FDirectorOct 19Buy1.1090,909100,000109,099Oct 21 05:04 PM
Nall Michael W.CEO & PresidentOct 19Buy1.1036,36339,99949,575Oct 21 06:43 PM
Chandler Marsha AlpertDirectorOct 19Buy1.104,5455,0005,212Oct 21 06:18 PM
Kennedy TimothyCFO, Sr V.P. Operations & Sec.Oct 19Buy1.1036,36339,99961,363Oct 21 06:17 PM
HUEBNER BRUCE ADirectorOct 19Buy1.1020,00022,00024,000Oct 21 06:16 PM
Gerhardt BruceDirectorOct 19Buy1.1050,00055,00073,304Oct 21 06:15 PM
Singh VeenaSr VP & Sr Med DirectorOct 19Buy1.1010,00011,00026,666Oct 21 06:14 PM
ARNOLD LYLE JSR VP of R&D and CSOOct 19Buy1.1045,00049,50065,238Oct 21 06:12 PM
Wilson Margaret FayeDirectorOct 19Buy1.1013,63615,00025,067Oct 21 06:11 PM
Reiss Claire10% OwnerOct 19Buy1.10227,272249,9991,046,613Oct 21 06:06 PM